Title: Optimizing dendritic cell vaccination for low-grade glioma patients
Investigators: Robert Prins and Linda Liau
Grantee: University of California Los Angeles
Vaccines that train the immune system to recognize and eliminate foreign invaders offer a powerful, personalized weapon in the fight against cancer. To specialize this weapon for use in brain cancer, Dr. Robert Prins and Dr. Linda Liau (University of California Los Angeles) are developing an anti-tumor vaccine called DCVax.